Blue Stone Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 15-12-2024
- Paid Up Capital ₹ 0.10 M
as on 15-12-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2020)
- Profit 282.20%
(FY 2020)
- Ebitda 6726.83%
(FY 2020)
- Net Worth 6.26%
(FY 2020)
- Total Assets 41.66%
(FY 2020)
About Blue Stone Life Sciences
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Srinivasanarendra Potluri and Kalki Bollina serve as directors at the Company.
- CIN/LLPIN
U01119AP2005PTC047841
- Company No.
047841
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Krishna, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Blue Stone Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kalki Bollina  | Director | 18-Jul-2008 | Current |
| Srinivasanarendra Potluri | Director | 15-Sep-2016 | Current |
Financial Performance and Corporate Structure Insights of Blue Stone Life Sciences.
Blue Stone Life Sciences Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 282.2% increase in profit. The company's net worth moved up by a moderate rise of 6.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Blue Stone Life Sciences?
In 2019, Blue Stone Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Growel Processors Private LimitedActive 14 years 3 months
Srinivasanarendra Potluri is a mutual person
Indian Naturals & Granules Private LimitedActive 16 years 7 monthsSrinivasanarendra Potluri is a mutual person
- Growel Life Sciences Private LimitedActive 10 years 12 days
Srinivasanarendra Potluri is a mutual person
- Vivamax Life Sciences Private LimitedActive 8 years 6 months
Srinivasanarendra Potluri and Kalki Bollina are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Blue Stone Life Sciences?
Unlock and access historical data on people associated with Blue Stone Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Blue Stone Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Stone Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
.webp){kind=small}
